JP2021536505A5 - - Google Patents
Info
- Publication number
- JP2021536505A5 JP2021536505A5 JP2021536673A JP2021536673A JP2021536505A5 JP 2021536505 A5 JP2021536505 A5 JP 2021536505A5 JP 2021536673 A JP2021536673 A JP 2021536673A JP 2021536673 A JP2021536673 A JP 2021536673A JP 2021536505 A5 JP2021536505 A5 JP 2021536505A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- solvate
- acceptable salt
- compound according
- alkyl
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862726915P | 2018-09-04 | 2018-09-04 | |
| US62/726,915 | 2018-09-04 | ||
| PCT/US2019/049374 WO2020051153A1 (en) | 2018-09-04 | 2019-09-03 | Muscarinic acetylcholine m1 receptor antagonists |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021536505A JP2021536505A (ja) | 2021-12-27 |
| JPWO2020051153A5 JPWO2020051153A5 (https=) | 2022-09-01 |
| JP2021536505A5 true JP2021536505A5 (https=) | 2022-09-01 |
| JP7460264B2 JP7460264B2 (ja) | 2024-04-02 |
Family
ID=69721873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536673A Active JP7460264B2 (ja) | 2018-09-04 | 2019-09-03 | ムスカリン性アセチルコリンｍ１受容体アンタゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12054487B2 (https=) |
| EP (1) | EP3846806A4 (https=) |
| JP (1) | JP7460264B2 (https=) |
| CN (2) | CN112638381B (https=) |
| AU (1) | AU2019336671B2 (https=) |
| CA (1) | CA3108076A1 (https=) |
| WO (1) | WO2020051153A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019241131A1 (en) | 2018-06-11 | 2019-12-19 | Pipeline Therapeutics, Inc. | Muscarinic acetylcholine m1 receptor antagonists |
| US12054487B2 (en) | 2018-09-04 | 2024-08-06 | Contineum Therapeutics, Inc. | Muscarinic acetylcholine M1 receptor antagonists |
| IL326597A (en) * | 2019-10-07 | 2026-04-01 | Contineum Therapeutics Inc | Muscarinic M1 acetylcholine receptor antagonists |
| US11752149B2 (en) | 2019-12-02 | 2023-09-12 | Pipeline Therapeutics, Inc. | Muscarinic acetylcholine M1 receptor antagonists |
| CN117279917A (zh) * | 2021-05-21 | 2023-12-22 | 成都百裕制药股份有限公司 | 哌嗪衍生物及其在医药上的应用 |
| EP4359401A1 (en) * | 2021-06-23 | 2024-05-01 | Blueprint Medicines Corporation | Process for preparing egfr inhibitors |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4803203A (en) | 1986-11-05 | 1989-02-07 | Warner-Lambert Company | Phenyl and heterocyclic piperazinyl alkoxy-benzheterocyclic compounds as antipsychotic agents |
| US4873331A (en) | 1988-12-09 | 1989-10-10 | American Home Products Corporation | Noradamantyl-carboxylic acid piperazinoalkyl esters |
| US5089497A (en) | 1990-09-20 | 1992-02-18 | Warner-Lambert Company | Substituted piperazines as central nervous system agents |
| CN1061350C (zh) * | 1995-12-21 | 2001-01-31 | 美国辉瑞有限公司 | 2,7－取代的八氢－吡咯并[1,2－a]吡嗪衍生物 |
| WO2003066595A2 (en) | 2002-02-01 | 2003-08-14 | Euro-Celtique S.A. | 2 - piperazine - pyridines useful for treating pain |
| EP1596867A4 (en) | 2003-02-19 | 2006-03-22 | Merck & Co Inc | TREATMENT OF PSYCHOSIS WITH A MUSCARIN M1 RECEPTOR ECTOPIC ACTIVATOR |
| CA2570903C (en) | 2004-07-26 | 2013-09-17 | Applied Research Systems Ars Holding N.V. | N-hydroxyamide derivatives and use thereof |
| WO2007064732A1 (en) | 2005-12-01 | 2007-06-07 | Schering Corporation | Compounds for the treatment of inflammatory disorders and microbial diseases |
| US20090156465A1 (en) | 2005-12-30 | 2009-06-18 | Sattigeri Jitendra A | Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| WO2012020567A1 (en) | 2010-08-09 | 2012-02-16 | Raqualia Pharma Inc. | Acyl piperazine derivatives as ttx-s blockers |
| WO2013049174A1 (en) | 2011-09-29 | 2013-04-04 | Abbvie Inc. | Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers |
| EP3153167B1 (en) | 2011-10-28 | 2019-10-02 | Vanderbilt University | Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| US8697888B2 (en) | 2012-01-06 | 2014-04-15 | Vanderbilt University | Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors |
| US20130289019A1 (en) | 2012-04-26 | 2013-10-31 | Amazing Grace, Inc. | Methods of treating behaviorial and/or mental disorders |
| BR112015006029B1 (pt) | 2012-09-18 | 2022-01-25 | Heptares Therapeutics Limited | Compostos aza bicíclicos como agonistas de receptor m1 muscarínicos, composição farmacêutica compreendendo ditos compostos e uso dos mesmos para tratar um distúrbio cognitivo ou distúrbio psicótico ou para tratar ou reduzir a gravidade de dores agudas, crônicas, neuropáticas ou inflamatórias |
| EP3371164B1 (en) * | 2015-11-06 | 2022-03-16 | Neurocrine Biosciences, Inc. | N-[2-(1-benzylpiperidin-4-yl)ethyl]-4-(pyrazin-2-yl)-piperazine-1-carboxamide derivatives and related compounds as muscarinic receptor 4 (m4) antagonists for treating neurological diseases |
| WO2018085803A1 (en) * | 2016-11-07 | 2018-05-11 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
| WO2018089433A1 (en) | 2016-11-08 | 2018-05-17 | Navitor Pharmaceuticals, Inc. | PHENYL mTORC INHIBITORS AND USES THEREOF |
| JP7291711B2 (ja) | 2018-02-15 | 2023-06-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｔｒｐｃ６阻害剤 |
| EP3788040B1 (en) | 2018-04-30 | 2023-04-12 | Ribon Therapeutics Inc. | Pyridazinones as parp7 inhibitors |
| WO2019241131A1 (en) | 2018-06-11 | 2019-12-19 | Pipeline Therapeutics, Inc. | Muscarinic acetylcholine m1 receptor antagonists |
| US12054487B2 (en) | 2018-09-04 | 2024-08-06 | Contineum Therapeutics, Inc. | Muscarinic acetylcholine M1 receptor antagonists |
| IL326597A (en) | 2019-10-07 | 2026-04-01 | Contineum Therapeutics Inc | Muscarinic M1 acetylcholine receptor antagonists |
| US11752149B2 (en) | 2019-12-02 | 2023-09-12 | Pipeline Therapeutics, Inc. | Muscarinic acetylcholine M1 receptor antagonists |
-
2019
- 2019-09-03 US US17/267,677 patent/US12054487B2/en active Active
- 2019-09-03 AU AU2019336671A patent/AU2019336671B2/en active Active
- 2019-09-03 EP EP19857624.1A patent/EP3846806A4/en active Pending
- 2019-09-03 WO PCT/US2019/049374 patent/WO2020051153A1/en not_active Ceased
- 2019-09-03 JP JP2021536673A patent/JP7460264B2/ja active Active
- 2019-09-03 CA CA3108076A patent/CA3108076A1/en active Pending
- 2019-09-03 CN CN201980057628.6A patent/CN112638381B/zh active Active
- 2019-09-03 CN CN202411263115.XA patent/CN119112895A/zh active Pending
-
2024
- 2024-06-18 US US18/747,272 patent/US20250026758A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021536505A5 (https=) | ||
| JP7555327B2 (ja) | Ｎｌｒｐ３インフラマソーム阻害剤 | |
| US11702422B2 (en) | Imidazopyridazines as modulators of IL-17 | |
| TWI662023B (zh) | 治療活性化合物及其使用方法（二） | |
| US20070142634A1 (en) | Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease | |
| JP5693814B2 (ja) | 新規のヒスタミンｈ３−受容体リガンドおよびそれらの治療的応用 | |
| JP6321825B2 (ja) | 神経形成を刺激することができるｎ−フェニル−ラクタム誘導体及び神経障害の処置におけるそれらの使用 | |
| JP2019034943A (ja) | Ｈｂｖ感染に対する新規抗ウイルス剤 | |
| JP2019069941A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| TW201331177A (zh) | 治療活性組合物及其使用方法 | |
| JP2011512359A (ja) | プロスタグランジンｄ２受容体のアンタゴニストとしての環式ジアリールエーテル化合物 | |
| KR20190004742A (ko) | 인돌아민 2,3-디옥시게나제의 억제제 및 그의 사용 방법 | |
| KR20230035049A (ko) | 화합물, 조성물 및 방법 | |
| JP2021528405A (ja) | ＲＯＲγｔのモジュレータとしてのアミド置換チアゾール | |
| JP2020518571A5 (https=) | ||
| JP7158464B2 (ja) | カリウムチャネル阻害剤としての置換ベンゾイミダゾール | |
| AU2023357827A1 (en) | Cyclopentane compound | |
| JP5661192B2 (ja) | ジヒドロオキサゾール−２−アミン誘導体 | |
| JPWO2020051153A5 (https=) | ||
| JP2021512910A5 (https=) | ||
| RU2011139287A (ru) | Оксииндольные производные, обладающие агонистической активностью в отношении мотилинового рецептора | |
| CN101602730B (zh) | 取代的咪唑衍生物 | |
| WO2012046771A1 (ja) | シクロアルカン化合物 | |
| WO2017008681A1 (zh) | 酰胺类衍生物、其制备方法及其在医药上的用途 | |
| TW202539691A (zh) | ＳＰＰＬ２ａ抑制劑 |